Minimally Invasive Direct Coronary Artery Bypass in High-Risk Patients with Multivessel Disease.

Background:  High-risk patients with multivessel disease (MVD) including a complex stenosis of the left anterior descending coronary may not be ideal candidates for guideline compliant therapy by coronary artery bypass grafting (CABG) regarding invasiveness and perioperative complications. However, they may benefit from minimally invasive direct coronary artery bypass (MIDCAB) grafting and hybrid revascularization (HCR).

Methods:  A logistic European system for cardiac operative risk evaluation score (logES) >10% defined high risk.